Health Highlights: May 13, 201405/13/14
Here are some of the latest health and medical news
developments, compiled by the editors of HealthDay:
Five More MERS Deaths in Saudi Arabia
Five more people in Saudi Arabia have died from the MERS
respiratory virus, health officials said Monday.
The deaths occurred in the capital Riyadh and the western cities
of Jiddah and Medina, according to the Saudi Health Ministry.
Since MERS was first identified in 2012, there have been 147
deaths and 491 confirmed cases in Saudi Arabia, the
Associated Pressreported. Most of the world's cases of MERS
and deaths from the disease have occurred in the kingdom.
Two MERS cases have been confirmed in the United States. The
latest case involved a resident of Saudi Arabia who was visiting
Florida. The man is being treated in an Orlando hospital.
The patient in the earlier, unassociated case was released from
an Indiana hospital late last week, the
APreported. That patient was a health care worker who'd had
close contact with MERS patients in Saudi Arabia.
MERS kills about one-quarter of people infected with the virus,
which can spread between people through close contact. It's
believed that camels carry the virus and can transmit it to
U.S. Company Donates Hemophilia Drugs to Poor Nations
A U.S. biotechnology company says it will donate hundreds of
millions of dollars worth of hemophilia drugs to developing
Biogen Idec Inc. of Cambridge, Mass. pledged to give 1 billion
units of clotting factor to poor nations in Africa, Asia and Latin
America over the next 10 years, the
People with hemophilia lack proteins required to control
bleeding. Clotting factor helps prevent uncontrollable bleeding in
patients with the inherited disorder. A person with severe
hemophilia may use up to 5,000 units of clotting factor a week.
Many hemophilia patients in poor countries can't afford
treatment. As a result, most don't live into adulthood, according
to Dr. David Kuter, chief of hematology at Massachusetts General
Biogen's announcement of its donation coincides with its launch
of new hemophilia drugs, the
Oil and Gas Wells on Federal, Indian Lands Lack Oversight:
Thousands of high-risk oil and gas wells on federal government
and Indian lands have not been inspected by the Interior
Department's Bureau of Land Management, according to a Government
Accountability Office report.
The audit said that weak oversight of wells that pose
potentially high risks for water contamination and other
environmental harm is due to incomplete monitoring data and
policies based on outdated science, the
The congressional investigators also said that the Bureau of
Land Management failed to coordinate effectively with state
regulators in New Mexico, North Dakota, Oklahoma and Utah.
The GAO said the bureau "cannot accurately and efficiently
identify whether federal and Indian resources are properly
protected or that federal and Indian resources are at risk of being
extracted without agency approval."
Copyright © 2014
. All rights reserved.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.